Related Experiment Video
Updated: Aug 17, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Pathological changes in GPCR signal organisation: Opportunities for targeted therapies for triple negative breast
Terrance Lam1, Chantel Mastos1, Erica K Sloan1
1Drug Discovery Biology Theme, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
Abstract:
Triple negative breast cancer (TNBC) has the poorest prognosis compared to other breast cancer subtypes, due to a historical lack of targeted therapies and high rates of relapse. Greater insight into the components of signalling pathways in TNBC tumour cells has led to the clinical evaluation, and in some cases approval, of targeted therapies. In the last decade, G protein-coupled receptors, such as the β2-adrenoceptor, have emerged as potential new therapeutic targets. Here, we describe how the β2-adrenoceptor accelerates TNBC progression in response to stress, and the unique signalling pathway activated by the β2-adrenoceptor to drive the invasion of an aggressive TNBC tumour cell. We highlight evidence that supports an altered organisation of GPCRs in tumour cells, and suggests that activation of the same GPCR in a different cellular location can control unique cell responses. Finally, we speculate how the relocation of GPCRs to the "wrong" place in tumour cells presents opportunities to develop targeted anti-cancer GPCR drugs with greater efficacy and minimal adverse effects.
Insights
Triple negative breast cancer (TNBC) progresses due to the β2-adrenoceptor, a G protein-coupled receptor (GPCR). Targeting GPCRs in unique cellular locations offers new therapeutic strategies for TNBC.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- Triple negative breast cancer (TNBC) has a poor prognosis and limited targeted therapies.
- G protein-coupled receptors (GPCRs), like the β2-adrenoceptor, are emerging as potential therapeutic targets.
- Understanding TNBC signaling pathways is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of the β2-adrenoceptor in TNBC progression and invasion.
- To elucidate the unique signaling pathway activated by β2-adrenoceptor in aggressive TNBC cells.
- To explore the therapeutic potential of targeting GPCRs in aberrant cellular locations.
Main Methods:
- Analysis of signaling pathways in TNBC tumor cells.
- Investigating the function of β2-adrenoceptor in response to stress.
- Studying GPCR organization and localization within tumor cells.
Main Results:
- The β2-adrenoceptor accelerates TNBC progression under stress.
- A unique signaling pathway activated by β2-adrenoceptor drives aggressive TNBC cell invasion.
- Evidence suggests altered GPCR organization in tumor cells, leading to unique cellular responses.
Conclusions:
- The β2-adrenoceptor is a key driver of TNBC progression and invasion.
- Aberrant GPCR localization in tumor cells presents novel therapeutic opportunities.
- Targeted anti-cancer GPCR drugs could offer improved efficacy and reduced side effects.
More Related Videos
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
GPCR Desensitization
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

